Abstract
The eating disorders discussed in this chapter include anorexia nervosa (AN), bulimia nervosa (BN), and a new diagnostic entity called binge eating disorder (BED), which appears to be prominent among the obese population. AN and BN have increased in prevalence over the last 20 years and are characterized by disturbed eating behavior and body image.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Casper R. C.: The pathophysiology of anorexia nervosa and bulimia nervosa. Annu Rev Nutr 6: 299–316, 1986.
Lucas A. R., Beard C. M., O’Fallon W. M., Kurland L. T.: 50-Year trends in the incidence of anorexia nervosa in Rochester, MN: A population-based study. Am J Psychiatry 148: 917–922, 1991.
Schotte D. E., Stunkard A. J.: Bulimia vs bulimic behaviors on acollege campus. JAMA 258: 1213–1215, 1987.
Fairburn C. G., Beglin S. J.: Studies of the epidemiology of bulimia nervosa. Am J Psychiatry 147: 401–408, 1990.
Pope H.g., Hudson J., Yurgium-Todd D.: Anorexia nervosa and bulimia among 300 women shoppers. Am J Psychiatry 141: 292–294, 1984.
Halmi K. A., Casper R. C., Eckert E. D., et al: Unique features associated with the age of onset of anorexia nervosa. Psychiatr Res 1: 209–215, 1979.
Cantwell D. P., Steuzenberger S., Burroughs J., Salkin B., Green J. K.: Anorexia nervosa: An affective disorder? Arch Gen Psychiatry 34: 1087–1093, 1977.
Gershon E. S., Schreiber J. L., Hamovit J. R., Dibble E. D., Kaye W., Nurnberger J. I., Jr., et al: Clinical findings in patients with anorexia nervosa and affective illness in their relatives. Am J Psychiatry 141: 1419–1422, 1984.
Hsu L. K. G., Crisp A. H., Harding B.: Outcome of anorexia nervosa. Lancet 1: 61–65, 1979.
Halmi K. A., Eckert E., Marchi P., Sampugnaro V., Apple R., Cohen J.: Comorbidity of psychiatric diagnoses in anorexia nervosa. Arch Gen Psychiatry 48: 712–718, 1991.
Brotman AW, Rigotti NA, Herzog DB. Medical complications of eating disorders. Compr Psychiatry 26: 258–272, 1985.
Garner D. M., Garfinkel P. E., Schwartz D., et al: Cultural expectations of thinness in women. Psychol Rep 47: 483–491, 1980.
Bruch H.: Eating Disorders: Obesity, Anorexia Nervosa and the Person Within. New York, Basic Books
Selvini Palazolli M.: Self-Starvation. London, Chaucer Publishing, 1974.
Geist R. A.: Psychotherapeutic dilemmas in the treatment of anorexia nervosa: A self-psychological perspective. Contemp Psychother Rev 2(Fal1), 1984.
Gilligan C.: In a Different Voice. Cambridge, Mass.: Harvard University Press, 1982
Steiner-Adair C. The body politic: Normal female adolescent development and the development of eating disorders. J Am Acad Psychoanal 14(1): 95–114, 1986.
Holland A. J., Sicotte N., Treasure J.: Anorexia nervosa: Evidence for a genetic basis. J Psychosom Res 32: 561–571, 1988.
Strober M., Lampert C., Morrell W., Burroughs J., Jacobs C.: A controlled family study of anorexia nervosa: Evidence of familial aggregation and lack of shared transmission with affective disorders. Int J Eating Disord 9: 239–253, 1990.
Kaye W. H., Jimerson D. C., Lake C. R., Ebert M. H.: Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa. Psychiatry Res 14: 333–342, 1985.
Kaye W. H., Gwirtsman H. E., George D. T., Ebert M. H.: Altered serotonin activity in anorexia nervosa after long term weight restoration: Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior? Arch Gen Psychiatry 48: 556–562.
America Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, D.C., American Psychiatric Press, 1994.
Walsh B. T.: Diagnostic criteria for eating disorders in DSM IV; work in progress. Int J Eating Disord 11: 301–304, 1992.
Herzog D. B., Keller M. B., Lavori P. W., Ott I. L.: Short-term prospective study of recovery in bulimia nervosa. Psychiatry Res 23: 45–55, 1987.
Keller M.B., Herzog D.B., Lavori P.W., Bradburn I.S., Mahoney E.M.: The naturalistic history of bulimia nervosa: Extraordinary high rates of chronicity, recurrence, and psychosocial morbidity. Int J Eating Disorders 12: 1–9, 1992.
Herzog D. B., Sacks N. R.: Bulimia nervosa: Comparison of treatment responders vs nonresponders. Psychopharmacol Bull 29(1): 121–125, 1993.
Herzog D. B., Copeland P. M.: Eating disorders. N Engl J Med 313: 481–487, 1985.
Polivy J., Herman C. P.: Dieting and hinging: A casual analysis. Am Psychol 40: 193–201, 1985.
Jimerson D. C., Lesem M. D., Hegg A. P., Brewerton T. D.: Serotonin in human eating disorders, in: Whitaker-Aximita P. M., Peroutka S. J. (eds): The Neuropharmacology of Serotonin, Annals of the New York Academy of Sciences, vol 600. New York, New York Academy of Sciences, 1990, pp 532–544.
Jimerson D. C., Lesem M. D., Kaye W. H., Brewerton T. D.: Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes. Arch Gen Psychiatry 49: 132–138, 1992.
Brewerton T. D., Mueller E. A., Lesem M. D., Brandt H. A., Quearry B., George D. T., et al: Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Arch Gen Psychiatry 49: 852–861, 1992.
Kaye W. H., Ballenger J. C., Lydiard R. B., Stuart G. W., Laraia M. T., O’Neil P., et al: CSF monoamine levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity. Am J Psychiatry 147: 225–229, 1990.
Jimerson D. C.: Brambilla F. (eds): Proceedings of the 2nd International Symposium on Disorders of Eating Behavior. Oxford, Pergamon Press 1996, pp. 57–62.
Morley J. E., Levine A. S., Gosnell B. A., Mitchell J. E., Krahn D. D., Nizielski S. E.: Peptides and feeding. Peptides 6: 181–192, 1985.
Geracioti T. D., Liddle R. A.: Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 319: 683–688, 1988.
Hudson J. I., Pope H. G., Jonas J. M., Yurgelun-Todd D.: Phenomenologic relationship of eating disorders to major affective disorder. Psychiatry Res 9: 345–354, 1983.
Piran N., Kennedy S., Garfinkel P. E., Owens M.: Affective disturbance in eating disorders. J Nerv Ment Dis 173: 395–400, 1985.
Walsh B. T., Roose S. P., Glassman A. H., Gladis M., Saidk C.: Bulimia and depression. Psychosom Med 47: 123–130. 1985.
Jimerson, D. C., Lesem M. D., Kaye W. H., Hegg A. P., Brewerton T. D.: Eating disorders and depression: Is there a serotonin connection? Biol Psychiatry 28: 443–454.
Hudson J. I., Pope H. G. Jr., Yurgelun-Todd D., Jonas J. M., Frankenburg F. R.: A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry 144: 1283–1287, 1987.
Fichter M. M., Quadflieg N., Rief W.: Course of multi-impulsive bulimia. Psychol Med 24: 591–604, 1994.
Spitzer R. L., Devlin M., Walsh B. T., Hasin D., Wing R., Marcus M., et al: Binge eating disorder: A multi-site field trial of the diagnostic criteria. Int J Eating Disord 11: 191–203, 1992.
Hudson J. I., Pope G. H., Wurtman J., Yurgelun-Todd D., Mark S., Rosenthal N. E.: Bulimia in obese individuals: Relationship to normal-weight bulimia. J Nevr Ment Dis 176: 144–152, 1988.
Devlin M. J., Walsh B. T., Spitzer R. L., Hasin D.: Is there another binge eating disorder? A review of the literature on overeating in the absence of bulimia nervosa. J Eating Disord 11: 333–340, 1992.
Fairburn C. G., Jones R., Peveler R. C., Carr S. J., Solomon R. A., O’Connor M. E., et al: Three psychological treatments for bulimia nervosa: A comparative trial. Arch Gen Psychiatry 48: 463–469, 1991.
Hsu L. K. G.: The outcome of anorexia nervosa: A reappraisal [Editorial], Psychol Med 18: 807–812.
Lacey J. H., Crisp A. H.: Hunger, food intake and weight, the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 56: 79–85, 1981.
Biederman J., Herzog D. B., Rivinus T.: Amitriptyline in anorexia nervosa: A double blind study. J Clin Psychopharmacol 5: 10–16, 1985.
Halmi K. A., Eckert E., LaDu T. H., Cohen J.: Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 43: 177–181, 1986.
Vigersky R. A., Loriaux D. L.: The effect of cyproheptadine in anorexia nervosa: A double blind trial, in Vigersky RA (ed): Anorexia Nervosa. New York, Raven Press, 1977, pp 349–356.
Gross H. A., Ebert M. H., Faden V. B., et al: A double blind controlled trial of lithium carbonate in primary anorexia nervosa. J Clin Psychopharmacol 1: 376–381, 1981.
Casper R. C., Schlemmer R. F. Jr., Javaid J. I.: A placebo controlled crossover study of oral clonidine in acute anorexia nervosa. Psychiatry Res 20: 249–260, 1987.
Moldofsky H., Jeuniewic N., Garfinkel P. E.: Preliminary report on metoclopramide in anorexia nervosa, in Vigersky RA (ed): Anorexia Nervosa. New York, Raven Press, 1977, pp 373–376.
Gross H., Ebert M. H., Faden V. B., Goldberg S. C., Kaye W. H., Caine E. D., et al: A double blind trial of delta-tetrahydrocannabinol in primary anorexia nervosa. J Clin Psychopharmacol 3: 165–171, 1983.
Vandereycken W., Pierloot R.: Pimozide combined with behavior therapy in the short term treatment of anorexia nervosa: A double blind, placebo-controlled, cross-over study. Acta Psychiatr Scand 66: 445–460, 1982.
Vandereycken W.: Neuroleptics in the short term treatment of anorexia nervosa: A double blind placebo controlled study with sulpiride. Br J Psychiatry 144: 288–292, 1984.
Gwirtsman H. E., Guze B. H., Yager J., Gainsley B.: Fluoxetine treatment of anorexia nervosa: An open clinical trial. J Clin Psychiatry 51: 378–382, 1990.
Kaye W. H., Weltzin T. E., Hsu L. K. G., Bulik C. M.: An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry 52: 464–471, 1991.
Hudson J. I., Pope H. G., Jonas J. M., et al: Treatment of anorexia nervosa with antidepressants. J Clin Psychopharmacol 5: 17–22, 1985.
Fahy T. A., Eisler I., Russell G. F.: A placebo controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry 162: 597–603, 1993.
Kennedy S. H., Goldbloom D. S., Ralevski E., Davis C., Dsouza J. D., Lofchy J.: Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo controlled trial of brofaromine. J Clin Psychopharmacol 13: 415–422, 1993.
Sabine E. T., Yonaie A., Forringten A. T., et al: Bulimia nervosa: A placebo controlled double blind trial of mianserin. Br J Clin Pharmacol 16: 1955–2025, 1983.
Pope H. G., Hudson J. I., Jones J. M., et al: Bulimia treated with imipramine: A placebo controlled double blind study. Am J Psychiatry 140: 554–558, 1983.
Walsh B. T., Gladis M., Roose S. P., et al: Phenelzine vs. placebo in 50 patients with bulimia. J Clin Psychopharmacol 9: 254–259, 1989.
Mitchell J. E., Grout R.: A placebo controlled double blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 4: 193–196, 1984.
Hughes, P. L., Wells L. A., Cunningham L. J., et al: Treating bulimia with desipramine: A placebo controlled double blind study. Arch Gen Psychiatry 43: 182–186, 1985.
Agras W. S., Dorian B., Kirkley B. J., et al: Imipramine in the treatment of bulimia: A double blind controlled study. Int J Eating Disord 6: 29–38, 1987.
Kaplan A. S.: Anticonvulsant treatment of eating disorders, in Garfinkel P. E., Garner D. M. (eds): The Role of Drug Treatments for Eating Disorders. New York, Brunner/Mazel, 1987, pp 181–192.
Blouin A. G., et al: Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 8: 261–269, 1988.
Barlow J., Blouin J. H., Blouin A., et al: Treatment of bulimia with desipramine: A double blind crossover study. Can J Psychiatry 330: 129–133, 1988.
Horne R. L., Ferguson J. M., Pope H. G. Jr., et al: Treatment of bulimia with bupropion: A multi-center controlled trial. J Clin Psychiatry 49: 262–266, 1988.
Kennedy S. H., et al: A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol 8: 391–396, 1988.
Mitchell J. E., Grout R.: A placebo controlled double blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 4(4): 186–193, 1984.
Pope H. G., Keck P. E., et al: A placebo controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol 9: 254–259, 1989.
Mitchell J. E., Pyle R. L., Eckert E. D., Hatsukami D., Pomeroy C., Zimmerman R.: A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 47: 149–157, 1990.
Walsh B. T., Hadigan C. M., Devlin M. J., Gladis M., Roose S. P.: Longterm outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry 148: 1206–1212, 1991.
Fichter M. M., Leibl K., Rief W., Brunner E., Schmidt-Auberger S., Engle R. R.: Fluoxetine versus placebo: A double blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry 24(1): 1–7, 1991.
Fluoxetine Bulimia Study Group: Fluoxetine in the treatment of bulimia nervosa: A multi-centered placebo controlled double blind trial. Arch Gen Psychiatry 49: 139–147, 1992.
McCann U. D., Agras W. S.: Successful treatment of nonpurging bulimia nervosa with desipramine: A double-blind, placebo controlled study. 147: 1509–1513, 1990.
Marcus M. D., Wing P. R., Weing L., Kern E., McDermott M., Gooding W.: A double-blind, placebo controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and nonbinge eaters. 147: 876–881, 1990.
Abraham S. F., Mira M., Llewellyn-Jones D.: Bulimia: A study of outcome. 2: 175–180, 1983.
Fichter N. M., Quadflieg N., Rief W.: The German longitudinal bulimia nervosa study I, in Herzog W., Deter H. C., Vandereycken W., (eds): The Course of Eating Disorders: Long-Time Follow-up Studies of Anorexia Nervosa and Bulimia Nervosa. Springer-Verlag, Berlin, 1992, pp 591–604.
Herzog D. B., Keller M. B., Lavori P. W., Ott I. L.: Short term prospective study of recovery in bulimia. Psychiatry Res 23: 45–55, 1988.
Herzog D. B., Keller M. B., Lavori P. W.: Outcome in anorexia nervosa and bulimia nervosa: A review of the literature. J Clin Psychiatry 53(5): 147–152, 1992.
Hsu L.K.: Eating Disorders. New York, Guilford Press, 1990.
Lacey H.: Bulimia nervosa, binge eating, and psychogenic vomiting: A controlled treatment study and long term outcome. Brit Med J 63: 433–442, 1988.
Mitchell J. E., Davis L., Goff G., et al: A follow up study of patients with bulimia. Int J Eat Disord 5: 441–450, 1986.
Pope H. G., Hudson J. I., Jonas J. M.: Antidepressant treatment of bulimia: Preliminary experience and practical recommendations. J Clin Psychopharmacol 3(5): 274–281, 1983.
Swift W. J., Kalin N. H., Wamboldt F. S., Kaslow N., Ritholz M.: Depression in bulimia at 2 to 5 year follow up. Psychiatry Res 16: 111, 1985.
APA Practice Guidelines: Practice guidelines for eating disorders. Am J Psychiatry 150(2): 209–228, 1993.
Jimerson D. C., Herzog D. B., and Brotman A. W.: Pharmacologic approaches in the treatment of eating disorders. Harvard Rev Psychiatry 1: 82–93, 1993.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brotman, A.W., Herzog, D.B., Jimerson, D.C. (1998). Eating Disorders. In: Gelenberg, A.J., Bassuk, E.L. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5877-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5877-4_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7695-8
Online ISBN: 978-1-4615-5877-4
eBook Packages: Springer Book Archive